CTLA-4 +49 A/G polymorphism is associated with predisposition to type 1 diabetes in Iranians
- 31 May 2005
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 68 (2) , 111-116
- https://doi.org/10.1016/j.diabres.2004.08.008
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Negative Regulation of T Cell Receptor–Lipid Raft Interaction by Cytotoxic T Lymphocyte–associated Antigen 4The Journal of Experimental Medicine, 2003
- Negative co-receptors on lymphocytesCurrent Opinion in Immunology, 2002
- Genetic control of autoimmunity in Type I diabetes and associated disordersDiabetologia, 2002
- Genetic linkage and association studies of Type I diabetes: challenges and rewardsDiabetologia, 2002
- Association studies of CTLA-4 , CD28 , and ICOS gene polymorphisms with type 1 diabetes in the Japanese populationImmunogenetics, 2001
- ICOS Costimulation Requires IL-2 and Can Be Prevented by CTLA-4 EngagementThe Journal of Immunology, 2001
- Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal InflammationThe Journal of Experimental Medicine, 2000
- Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4The Journal of Experimental Medicine, 2000
- Molecular Basis of T Cell Inactivation by CTLA-4Science, 1998
- CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.The Journal of Experimental Medicine, 1996